Literature DB >> 16258729

Mobilization and activation of a signaling competent alpha6beta4integrin underlies its contribution to carcinoma progression.

Elizabeth A Lipscomb1, Arthur M Mercurio.   

Abstract

This review examines the hypothesis that the function of the alpha 6beta 4 integrin is altered substantially as normal epithelia undergo malignant transformation and progress to invasive carcinoma and that the functions of this integrin contribute to the behavior of aggressive carcinoma cells. Specifically, alpha 6beta 4 functions primarily as an adhesion receptor in normal epithelia, often as a component of hemidesmosomes and associated with intermediate filaments. Factors in the host-tumor microenvironment have the potential to mobilize alpha 6beta 4 from hemidesmosomes and promote its association with F-actin in lamellae and filopodia, a process that is mediated by PKC-dependent phosphorylation of the beta 4 cytoplasmic domain. Importantly, this altered localization of alpha 6beta 4 appears to be coupled to an activation of its signaling potential, which may occur through its association with growth factor receptors or lipid rafts, possibilities that are not mutually exclusive. The primal signaling event triggered by alpha 6beta 4 appears to be activation of PI3-K and this activation has profound consequences on the migration, invasion and survival of carcinoma cells. Arguably, the ability of alpha 6beta 4 to stimulate the PI3-K-dependent translation of VEGF and possibly other growth factors may be the most significant contribution of this integrin to carcinoma because of the potential autocrine and paracrine effects of these factors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16258729     DOI: 10.1007/s10555-005-5133-4

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  69 in total

1.  Integrin β4 regulates SPARC protein to promote invasion.

Authors:  Kristin D Gerson; Jeffrey R Shearstone; V S R Krishna Maddula; Bruce E Seligmann; Arthur M Mercurio
Journal:  J Biol Chem       Date:  2012-02-03       Impact factor: 5.157

2.  Slug/SNAI2 regulates cell proliferation and invasiveness of metastatic prostate cancer cell lines.

Authors:  Modjtaba Emadi Baygi; Zahra-Soheila Soheili; Frank Essmann; Abdolkhaleg Deezagi; Rainer Engers; Wolfgang Goering; Wolfgang A Schulz
Journal:  Tumour Biol       Date:  2010-05-27

3.  Palmitoylation by DHHC3 is critical for the function, expression, and stability of integrin α6β4.

Authors:  Chandan Sharma; Isaac Rabinovitz; Martin E Hemler
Journal:  Cell Mol Life Sci       Date:  2012-07       Impact factor: 9.261

4.  Structural basis of the interaction between integrin alpha6beta4 and plectin at the hemidesmosomes.

Authors:  José M de Pereda; M Pilar Lillo; Arnoud Sonnenberg
Journal:  EMBO J       Date:  2009-02-26       Impact factor: 11.598

5.  Integrin alpha6beta4 controls the expression of genes associated with cell motility, invasion, and metastasis, including S100A4/metastasin.

Authors:  Min Chen; Mala Sinha; Bruce A Luxon; Anne R Bresnick; Kathleen L O'Connor
Journal:  J Biol Chem       Date:  2008-11-14       Impact factor: 5.157

6.  Id2 complexes with the SNAG domain of Snai1 inhibiting Snai1-mediated repression of integrin β4.

Authors:  Cheng Chang; Xiaofang Yang; Bryan Pursell; Arthur M Mercurio
Journal:  Mol Cell Biol       Date:  2013-07-22       Impact factor: 4.272

7.  Integrin α6β4 Promotes Autocrine Epidermal Growth Factor Receptor (EGFR) Signaling to Stimulate Migration and Invasion toward Hepatocyte Growth Factor (HGF).

Authors:  Brittany L Carpenter; Min Chen; Teresa Knifley; Kelley A Davis; Susan M W Harrison; Rachel L Stewart; Kathleen L O'Connor
Journal:  J Biol Chem       Date:  2015-09-17       Impact factor: 5.157

8.  AhR ligand aminoflavone suppresses α6-integrin-Src-Akt signaling to attenuate tamoxifen resistance in breast cancer cells.

Authors:  Petreena S Campbell; Nicole Mavingire; Salma Khan; Leah K Rowland; Jonathan V Wooten; Anna Opoku-Agyeman; Ashley Guevara; Ubaldo Soto; Fiorella Cavalli; Andrea Irene Loaiza-Pérez; Gayathri Nagaraj; Laura J Denham; Olayemi Adeoye; Brittany D Jenkins; Melissa B Davis; Rachel Schiff; Eileen J Brantley
Journal:  J Cell Physiol       Date:  2018-08-04       Impact factor: 6.384

9.  The CD34-like protein PODXL and alpha6-integrin (CD49f) identify early progenitor MSCs with increased clonogenicity and migration to infarcted heart in mice.

Authors:  Ryang Hwa Lee; Min Jeong Seo; Andrey A Pulin; Carl A Gregory; Joni Ylostalo; Darwin J Prockop
Journal:  Blood       Date:  2008-09-25       Impact factor: 22.113

10.  Integrin signaling aberrations in prostate cancer.

Authors:  Hira Lal Goel; Naved Alam; Isaac N S Johnson; Lucia R Languino
Journal:  Am J Transl Res       Date:  2009-04-20       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.